NASDAQ:VLRX - Valeritas Stock Price, News & Analysis

$2.22
-0.07 (-3.06 %)
(As of 08/22/2019 02:46 PM ET)
Today's Range
$2.1610
Now: $2.22
$2.3216
50-Day Range
$2.26
MA: $2.72
$3.70
52-Week Range
$2.10
Now: $2.22
$33.20
Volume66,782 shs
Average Volume477,992 shs
Market Capitalization$11.79 million
P/E RatioN/A
Dividend YieldN/A
Beta1.79
Valeritas Holdings, Inc, a commercial-stage medical technology company, focuses on the development and commercialization of technologies to treat patients with Type 2 diabetes in the United States. The company offers V-Go, a wearable insulin delivery device for basal-bolus therapy. It also develops V-Go Prefill that is in the design-development stage for eliminating the device-filling process and the need for EZ fill refrigeration for patients with Type 2 diabetes; and V-Go SIM for real-time tracking information of basal and bolus dosing utilization. Read More…

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:VLRX
CUSIPN/A
Phone908-927-9920

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$26.40 million
Book Value($1.49) per share

Profitability

Net Income$-45,930,000.00
Net Margins-187.83%
Return on Equity-45,700.07%

Miscellaneous

Employees125
Market Cap$11.79 million
Next Earnings Date11/8/2019 (Estimated)
OptionableNot Optionable

Receive VLRX News and Ratings via Email

Sign-up to receive the latest news and ratings for VLRX and its competitors with MarketBeat's FREE daily newsletter.


Valeritas (NASDAQ:VLRX) Frequently Asked Questions

What is Valeritas' stock symbol?

Valeritas trades on the NASDAQ under the ticker symbol "VLRX."

How were Valeritas' earnings last quarter?

Valeritas Holdings Inc (NASDAQ:VLRX) posted its earnings results on Thursday, August, 8th. The company reported ($2.73) EPS for the quarter, beating the Zacks' consensus estimate of ($2.90) by $0.17. The company had revenue of $7.51 million for the quarter, compared to analysts' expectations of $7.50 million. Valeritas had a negative net margin of 187.83% and a negative return on equity of 45,700.07%. View Valeritas' Earnings History.

When is Valeritas' next earnings date?

Valeritas is scheduled to release their next quarterly earnings announcement on Friday, November 8th 2019. View Earnings Estimates for Valeritas.

What guidance has Valeritas issued on next quarter's earnings?

Valeritas issued an update on its FY 2019 earnings guidance on Thursday, August, 8th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $31-33 million, compared to the consensus revenue estimate of $32.45 million.

What price target have analysts set for VLRX?

2 brokers have issued 12 month target prices for Valeritas' stock. Their forecasts range from $12.00 to $14.00. On average, they expect Valeritas' share price to reach $13.00 in the next twelve months. This suggests a possible upside of 496.3% from the stock's current price. View Analyst Price Targets for Valeritas.

What is the consensus analysts' recommendation for Valeritas?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Valeritas in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Valeritas.

Has Valeritas been receiving favorable news coverage?

News headlines about VLRX stock have been trending positive on Thursday, according to InfoTrie Sentiment Analysis. InfoTrie identifies negative and positive news coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Valeritas earned a media sentiment score of 2.5 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 6.0 out of 10, indicating that recent news coverage is somewhat likely to have an impact on the stock's share price in the next several days. View News Stories for Valeritas.

Who are some of Valeritas' key competitors?

What other stocks do shareholders of Valeritas own?

Who are Valeritas' key executives?

Valeritas' management team includes the folowing people:
  • Mr. John E. Timberlake, Pres, CEO & Director (Age 54)
  • Mr. Erick J. Lucera CPA, CFA, CFO & Sec. (Age 51)
  • Mr. Geoffrey H. Jenkins, Exec. VP of Manufacturing, Operations and R&D (Age 67)
  • Dr. Matthew H. Nguyen, Chief Commercial Officer (Age 49)
  • Mr. Scott A. Huie, VP of Regulatory Affairs/Quality Assurance and Compliance

When did Valeritas IPO?

(VLRX) raised $60 million in an initial public offering on Thursday, March 23rd 2017. The company issued 6,000,000 shares at $9.00-$11.00 per share. Cowen and Company and Wedbush PacGrow served as the underwriters for the IPO and Roth Capital Partners and B. Riley & Co. were co-managers.

Who are Valeritas' major shareholders?

Valeritas' stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (1.82%), Cutter & CO Brokerage Inc. (0.83%), Bank of New York Mellon Corp (0.49%) and Gabelli Funds LLC (0.23%). Company insiders that own Valeritas stock include Armistice Capital Master Fund, John Edward Timberlake, Joseph M Mandato, Matt Nguyen, Matt Nguygn and Peter Devlin. View Institutional Ownership Trends for Valeritas.

Which major investors are selling Valeritas stock?

VLRX stock was sold by a variety of institutional investors in the last quarter, including Vanguard Group Inc. and Gabelli Funds LLC. View Insider Buying and Selling for Valeritas.

Which major investors are buying Valeritas stock?

VLRX stock was purchased by a variety of institutional investors in the last quarter, including Cutter & CO Brokerage Inc. and Bank of New York Mellon Corp. Company insiders that have bought Valeritas stock in the last two years include Armistice Capital Master Fund, John Edward Timberlake, Joseph M Mandato, Matt Nguyen, Matt Nguygn and Peter Devlin. View Insider Buying and Selling for Valeritas.

How do I buy shares of Valeritas?

Shares of VLRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Valeritas' stock price today?

One share of VLRX stock can currently be purchased for approximately $2.18.

How big of a company is Valeritas?

Valeritas has a market capitalization of $11.58 million and generates $26.40 million in revenue each year. The company earns $-45,930,000.00 in net income (profit) each year or ($34.20) on an earnings per share basis. Valeritas employs 125 workers across the globe.View Additional Information About Valeritas.

What is Valeritas' official website?

The official website for Valeritas is http://www.valeritas.com/.

How can I contact Valeritas?

Valeritas' mailing address is 750 ROUTE 202 SOUTH SUITE 600, BRIDGEWATER NJ, 08807. The company can be reached via phone at 908-927-9920 or via email at [email protected]


MarketBeat Community Rating for Valeritas (NASDAQ VLRX)

Community Ranking:  3.3 out of 5 (star star star)
Outperform Votes:  212 (Vote Outperform)
Underperform Votes:  114 (Vote Underperform)
Total Votes:  326
MarketBeat's community ratings are surveys of what our community members think about Valeritas and other stocks. Vote "Outperform" if you believe VLRX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe VLRX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 8/22/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel